Key Market Indicators
Austrian antacid medicine sales are expected to hit $1.9 million by 2026. This represents a 3.9% annual growth rate from 2021, when sales hit $1.5 million. Since 2015, the Austrian market has grown by 20.8% year-on-year. In 2021, it came in at number 14, with Costa Rica overtaking it at $1.5 million. Italy, Germany, and Chile ranked numbers two, three, and four respectively in the ranking.
